AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate

COVID-19 is a novel disease caused by SARS-CoV-2 which has conquered the world rapidly resulting in a pandemic that massively impacts our health, social activities, and economy. It is likely that vaccination is the only way to form “herd immunity” and restore the world to normal. Here we developed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuelan, Chang, Xinyue, Rothen, Dominik, Derveni, Mariliza, Krenger, Pascal, Roongta, Salony, Wright, Edward, Vogel, Monique, Tars, Kaspars, Mohsen, Mona O., Bachmann, Martin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073683/
https://www.ncbi.nlm.nih.gov/pubmed/33921677
http://dx.doi.org/10.3390/vaccines9040403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073683/
https://www.ncbi.nlm.nih.gov/pubmed/33921677
http://dx.doi.org/10.3390/vaccines9040403

Ejemplares similares